Cytoplasmic HuR over‐expression is associated with increased cyclooxygenase‐2 expression in laryngeal squamous cell carcinomas

References

• Ferlito A., Shaha A. R., Silver C. E., Rinaldo A., Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 202–7
   PubMed Web of Science ®Google Scholar
• Karamouzis M. V., Sotiropoulou‐Bonikou G., Vandoros G., et al. Differential expression of retinoic acid receptor beta (RARbeta) and the AP‐1 transcription factor in normal, premalignant and malignant human laryngeal tissues. Eur J Cancer 2004; 40: 761–73
   PubMed Web of Science ®Google Scholar
• Hoffman H. T., Karnell L. H., Funk G. F., et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 951–62
   PubMedGoogle Scholar
• Tabor M. P., Brakenhoff R. H., Ruijter‐Schippers H. J., et al. Multiple head and neck tumours frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161: 1051–60
   PubMed Web of Science ®Google Scholar
• Day G. L., Blot W. J. Second primary tumors in patients with oral cancer. Cancer 1992; 70: 14–9
   PubMed Web of Science ®Google Scholar
• Farber E. The multistep nature of cancer development. Cancer Res 1984; 44: 4217–25
   PubMed Web of Science ®Google Scholar
• Licitra L., Bernier J., Grandi C., et al. Cancer of the larynx. Crit Rev Oncol Hematol 2003; 45: 65–80
   Web of Science ®Google Scholar
• Rafferty M. A., Fenton J. E., Jones A. S. An overview of the role and inter‐relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. Clin Otolaryngol 2001; 26: 317–20
   PubMed Web of Science ®Google Scholar
• Sachs A. B. Messenger RNA degradation in eukaryotes. Cell 1993; 74: 413–21
   PubMed Web of Science ®Google Scholar
• Pan Y. X., Chen H., Kilberg M. S. Interaction of RNA‐binding proteins HuR and AUF1 with the human ATF3 mRNA 3′‐untranslated region regulates its amino acid limitation‐induced stabilization. J Biol Chem 2005; 280: 34609–16
   PubMed Web of Science ®Google Scholar
• Brennan C. M., Steitz J. A. HuR and mRNA stability. Cell Mol Sci 2001; 58: 266–77
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K., Marmao T. P., Dixon D. A., et al. Regulation of cyclooxygenase‐2 mRNA stability by taxanes. Evidence for involvement of p38, MAPKAPK‐2 and HuR. J Biol Chem 2003; 278: 37637–47
   PubMed Web of Science ®Google Scholar
• Gantt K., Cherry J., Tenney R., et al. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer‐binding protein β (C/EBPβ) mRNA by HuR and its translocation to the cytosol. J Biol Chem 2005; 280: 24768–74
   PubMed Web of Science ®Google Scholar
• Lu J. Y., Schneider R. J. Tissue distribution of AU‐rich mRNA‐binding proteins involved in regulation of mRNA decay. J Biol Chem 2004; 279: 12974–9
   PubMed Web of Science ®Google Scholar
• Gallouzi I. E., Steitz J. A. Delineation of mRNA export pathways by the use of cell‐permeable peptides. Science 2001; 294: 1895–901
   PubMed Web of Science ®Google Scholar
• Nabors L. B., Gillespie G. Y., Harkins L., et al. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine‐ and uridine‐rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 2001; 61: 2154–61
   PubMed Web of Science ®Google Scholar
• Denkert C., Weichert W., Winzer K. J., et al. Expression of the ELAV‐Like protein HuR is associated with higher tumor grade and increased cyclooxygenase‐2 expression in human breast carcinoma. Clin Cancer Res 2004; 10: 5580–6
   PubMed Web of Science ®Google Scholar
• Dixon D. A., Tolley N. D., King P. H., et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase‐2 expression in colon cancer cells. J Clin Invest 2001; 108: 1657–65
   PubMed Web of Science ®Google Scholar
• Denkert C., Weichert W., Pest S., et al. Overexpression of the embryonic‐lethal abnormal vision‐like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 2004; 64: 189–95
   PubMed Web of Science ®Google Scholar
• Guhaniyogi J., Brewer G. Regulation of mRNA stability in mammalian cells. Gene 2001; 265: 11–23
   PubMed Web of Science ®Google Scholar
• Jung T. T. K., Berlinger N. T., Juhn S. K. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope 1985; 95: 307–12
   PubMed Web of Science ®Google Scholar
• Bennett A., Carroll M. A., Stamford I. F., et al. Prostaglandins and human lung carcinomas. Br J Cancer 1982; 46: 888–93
   PubMed Web of Science ®Google Scholar
• Rigas B., Goldman I. S., Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122: 518–23
   PubMed Web of Science ®Google Scholar
• Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705–16
   PubMed Web of Science ®Google Scholar
• Williams C. S., Tsujii M., Reese J., et al. Host cyclooxygenase‐2 modulates carcinoma growth. J Clin Invest 2000; 105: 1589–94
   PubMed Web of Science ®Google Scholar
• Goodwin J. S., Ceuppens J. L. Regulation of immune response by prostaglandins. J Clin Immunol 1983; 295–315, 1983; 3
   PubMed Web of Science ®Google Scholar
• Sheng H., Shao J., Marrow J. D., et al. Modulation of apoptosis and Bcl‐2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362–6
   PubMed Web of Science ®Google Scholar
• Schreinemachers D. M., Everson R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138–46
   PubMed Web of Science ®Google Scholar
• Funkhouser E. M., Sharp G. B. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76: 1116–9
   PubMed Web of Science ®Google Scholar
• Castonguay A., Rioux N. Inhibition of lung tumorigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis 1997; 18: 491–6
   PubMed Web of Science ®Google Scholar
• Boolbol S. K., Dannenberg A. J., Chadburn A., et al. Cyclooxygenase‐2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996; 56: 2556–60
   PubMed Web of Science ®Google Scholar
• Erkinheimo T. L., Lassus H., Sivula A., et al. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 2003; 63: 7591–4
   PubMed Web of Science ®Google Scholar
• Shanmugaratnam K., Sobin L. H. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 1993; 71: 2689–97
   PubMed Web of Science ®Google Scholar
• Heinonen M., Bono P., Narko K., et al. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 2005; 65: 2157–61
   PubMed Web of Science ®Google Scholar
• Lopez de Silanes I., Fan J., Yang X., et al. Role of the RNA‐binding protein HuR in colon carcinogenesis. Oncogene 2003; 22: 7146–54
   PubMed Web of Science ®Google Scholar
• Fan X. C., Steitz J. A. Overexpression of HuR, a nuclear‐cytoplasmic shuttling protein, increased the in vivo stability of ARE‐containing mRNAs. EMBO J 1998; 17: 3448–60
   PubMed Web of Science ®Google Scholar
• Wang W., Caldwell M. C., Lin S., et al. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 2000; 19: 2340–50
   PubMed Web of Science ®Google Scholar
• Wein G., Rossler M., Klug R., et al. The 3′‐UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU‐rich element interacting with the mRNA stabilizing factors HuD and HuR. Eur J Biochem 2003; 270: 350–65
   PubMedGoogle Scholar
• Peng S. S., Chen C. Y., Xu N., et al. RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein. EMBO J 1998; 17: 3461–70
   PubMed Web of Science ®Google Scholar
• Tran H., Maurer F., Nagamine Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen‐activated protein kinase‐activated protein kinase 2. Mol Cell Biol 2003; 23: 7177–88
   PubMed Web of Science ®Google Scholar
• Bayazit Y. A., Buyukberber S., Sari I., et al. Cyclo‐oxygenase 2 expression in laryngeal squamous cell carcinoma and its clinical correlates. ORL J Otorhinolaryngol Relat Spec 2004; 66: 65–9
   PubMed Web of Science ®Google Scholar
• Sun X., Ge R., Dong Q., et al. The expression of cyclooxygenase‐2 in laryngeal squamous cell carcinoma and its relationship with MVD. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005; 19: 967–70
   PubMedGoogle Scholar
• Hur K., Song S. H., Lee H. S., et al. Aberrant methylation of the specific CpG island portion regulates cyclooxygenase‐2 gene expression in human gastric carcinomas. Biochem Biophys Res Commun 2003; 310: 844–51
   PubMed Web of Science ®Google Scholar